FDA approves Vitestro’s robotic blood draw device

FDA approves Vitestro's Aletta robotic blood draw device. See how AI and ultrasound automate phlebotomy without human operators.

President Trump appoints physician Heidi Overton as the new FDA commissioner to oversee drug approvals and health regulations.

Black women face higher heart failure risk due to racism and childhood trauma, a new study reveals. Learn…

Clinical trials for alopecia areata therapies often exclude children under 12, limiting treatment options and data for pediatric…

Discover how pazopanib increases SERPINE1 levels to signal tumor response. Explore treatment options for soft tissue sarcoma and…

Explore how a dual GLP-1 agonist may improve obesity-related liver disease, with Phase 2 trial data highlighting histologic…

DLBCL radiotherapy offers strong consolidation after R-CHOP, though experts outline specific limitations for advanced-stage patients in clinical reviews.

Psoriasis and metabolic syndrome often occur together due to IL-17 signaling. Learn how these conditions are linked and…

Rare sarcoma trials are being unified under the OCTOPUS master protocol to speed drug development for ultra‑rare cancers,…

A new cancer drug reduces disease progression risk by 68% compared to chemotherapy in CLL and SLL patients,…